Concise review: Stem cell-derived erythrocytes as upcoming players in blood transfusion

Stem Cells

Volumn 30, Issue 8, 2012, Pages 1587-1596

  Zeuner, Ann ^a   Martelli, Fabrizio ^a   Vaglio, Stefania ^a   Federici, Giulia ^a   Whitsett, Carolyn ^b,c   Migliaccio, Anna Rita ^a,c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b KINGS COUNTY HOSPITAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adult hematopoietic stem cells; Anemia; Cord blood; Embryonic stem cells; Erythropoiesis; Induced pluripotent stem cells

Indexed keywords

BLOOD GROUP ANTIGEN; CD34 ANTIGEN; ERYTHROPOIETIN; GLUCOCORTICOID; GROWTH FACTOR; HEMOGLOBIN; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA;

ADULT; ADULT STEM CELL; AFRICAN AMERICAN; ANEMIA; ANTIGEN EXPRESSION; BLOOD DONOR; BLOOD TRANSFUSION; CELL CULTURE; CELL MATURATION; EMBRYO; EMBRYONIC STEM CELL; ERYTHROBLAST; ERYTHROCYTE; ERYTHROID CELL; ERYTHROPOIESIS; ETHNICITY; EX VIVO STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; MEDICAL TECHNOLOGY; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; PROTEOMICS; QUALITATIVE RESEARCH; QUANTITATIVE ANALYSIS; REVIEW; SICKLE CELL ANEMIA;

ANIMALS; BLOOD TRANSFUSION; DISEASE MODELS, ANIMAL; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; MICE;

EID: 84864370350     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1136     Document Type: Review

References (57)

1. Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective. Blood 2008;112:2617-2626.
2. Report of the US Department of Health and Human Services. The 2009 National Blood Collection and Utilization Survey Report. Washington, DC: ed. Services, T.U.D.o.H.a.H.; 2010.
3. Ali A, Auvinen MK, Rautonen J. The aging population poses a global challenge for blood services. Transfusion 2010;50:584-588.
4. Zimring JC, Welniak L, Semple JW et al. Current problems and future directions of transfusion-induced alloimmunization: Summary of an NHLBI working group. Transfusion 2011;51:435-441.
5. Papayannopoulou Th, Abkowitz J, D'Andrea A et al. Biology of erythropoiesis, erythroid differentiation and maturation. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, Heslop H, eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, PA: Elsevier, 2009:276-299.
6. Crispino JD. GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 2005;16:137-147. (Pubitemid 40126884)
7. De Maria R, Zeuner A, Eramo A et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 1999;401:489-493.
8. Ribeil JA, Zermati Y, Vandekerckhove J et al. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature 2007;445:102-105. (Pubitemid 46067309)
9. Peschle C, Testa U, Valtieri M et al. Stringently purified human hematopoietic progenitors/stem cells: Analysis of cellular/molecular mechanisms underlying early hematopoiesis. Stem Cells 1993;11:356-370. (Pubitemid 24007584)
10. Fibach E, Manor D, Oppenheim A et al. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989;73:100-103. (Pubitemid 19040960)
11. Panzenbock B, Bartunek P, Mapara MY et al. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood 1998;92:3658-3668. (Pubitemid 28525191)
12. von Lindern M, Zauner W, Mellitzer G et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 1999;94:550-559. (Pubitemid 29323869)
13. Migliaccio G, Di Pietro R, di Giacomo V et al. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis 2002;28:169-180. (Pubitemid 34743751)
14. Migliaccio AR, Whitsett C, Migliaccio G. Erythroid cells in vitro: From developmental biology to blood transfusion products. Curr Opin Hematol 2009;16:259-268.
15. Chasis JA, Mohandas N. Erythroblastic islands: Niches for erythropoiesis. Blood 2008;112:470-478.
16. Majka M, Janowska-Wieczorek A, Ratajczak J et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001;97:3075-3085.
17. Migliaccio G, Masiello F, Tirelli V et al. Under HEMA conditions, self-replication of human erythroblasts is limited by autophagic death. Blood Cells Mol Dis 2011;47:182-197.
18. Hiroyama T, Miharada K, Sudo K et al. Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One 2008;3:e1544.
19. Giarratana MC, Rouard H, Dumont A et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood 2011;118:5071-5079.
20. Neildez-Nguyen TM, Wajcman H, Marden MC et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 2002;20:467-472. (Pubitemid 34495932)
21. Ende M, Ende N. Hematopoietic transplantation by means of fetal (cord) blood. A new method. Va Med Mon (1918) 1972;99:276-280.
22. Broxmeyer HE. Umbilical cord transplantation: Epilogue. Semin Hematol 2010;47:97-103.
23. Peyrard T, Bardiaux L, Krause C et al. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: Potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev 2011;25:206-216.
24. Migliaccio G, Sanchez M, Masiello F et al. Humanized culture medium for clinical expansion of human erythroblasts. Cell Transplant 2010;19:453-469.
25. Lu SJ, Feng Q, Park JS et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008;112:4475-4484.
26. Lapillonne H, Kobari L, Mazurier C et al. Red blood cell generation from human induced pluripotent stem cells: Perspectives for transfusion medicine. Haematologica 2010;95:1651-1659.
27. Hiroyama T, Miharada K, Kurita R et al. Plasticity of cells and ex vivo production of red blood cells. Stem Cells Int 2011;2011:195780.
28. Chang KH, Nelson AM, Fields PA et al. Diverse hematopoietic potentials of five human embryonic stem cell lines. Exp Cell Res 2008;314:2930-2940.
29. Chang KH, Huang A, Hirata RK et al. Globin phenotype of erythroid cells derived from human induced pluripotent stem cells. Blood 2010;115:2553-2554.
30. Chang CJ, Mitra K, Koya M et al. Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells. PLoS One 2011;6:e25761.
31. Papapetrou EP, Lee G, Malani N et al. Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol 2011;29:73-78.
32. Nakamura S, Takayama N, Hiromitsu N et al. Platelet production system using an immortalized magakaryoctic cell line derived from human pluripotent stem cells. Blood 2011;118:3a.
33. Wang Y, Ono Y, Ikeda Y et al. Induction of megakaryocytes from fibroblasts by p45NF-E2/Maf. Blood 2011;11:908a.
34. England SJ, McGrath KE, Frame JM et al. Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus. Blood 2011;117:2708-2717.
35. Zeuner A, Francescangeli F, Signore M et al. The Notch2-Jagged1 interaction mediates stem cell factor signaling in erythropoiesis. Cell Death Differ 2011;18:371-380.
36. Zhou J, Cidlowski JA. The human glucocorticoid receptor: One gene, multiple proteins and diverse responses. Steroids 2005;70:407-417. (Pubitemid 40616039)
37. VanMeter A, Signore M, Pierobon M et al. Reverse-phase protein microarrays: Application to biomarker discovery and translational medicine. Expert Rev Mol Diagn 2007;7:625-633. (Pubitemid 47547727)
38. Van Iersel MP, Kelder T, Pico AR et al. Presenting and exploring biological pathways with PathVisio. BMC Bioinformatics 2008;9:399.
39. Forejtnikova H, Vieillevoye M, Zermati Y et al. Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis. Blood 2010;116:5357-5367.
40. Keel SB, Doty RT, Yang Z et al. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 2008;319:825-828. (Pubitemid 351225875)
41. Ghinassi B, Themeli M, Chang K-H et al. Comparative blood group profiling of human erythroid cells (EBs) generated from adult blood (AB), Cord Blood (CB), human embryonic stem cells (hESC) and induced pluripotent stem cells (iPS). Blood 2011;118:475 (travel award).
42. Varricchio L, Fabucci ME, Alfani E et al. Compensated variability in the expression of globin-related genes in erythroblasts generated ex vivo from different donors. Transfusion 2010;50:672-684.
43. Liu J, Mohandas N, An X. Membrane assembly during erythropoiesis. Curr Opin Hematol 2011;18:133-138.
44. Chen K, Liu J, Heck S et al. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci USA 2009;106: 17413-17418.
45. Satchwell TJ, Bell AJ, Pellegrin S et al. Critical band 3 multiprotein complex interactions establish early during human erythropoiesis. Blood 2011;118:182-191.
46. Carilli AR, Sugrue MW, Rosenau EH et al. African American adult apheresis donors respond to granulocyte-colony-stimulating factor with neutrophil and progenitor cell yields comparable to those of Caucasian and Hispanic donors. Transfusion 2012;52:166-172.
47. Tirelli V, Masiello F, Sanchez M et al. Effects of ontogeny, ethnicity, gender and loss of companion cells on ex-vivo expansion of erythroid cells for transfusion. Blood 2011;118:563.
48. Ney PA. Normal and disordered reticulocyte maturation. Curr Opin Hematol 2011;18:152-157.
49. Keerthivasan G, Wickrema A, Crispino JD. Erythroblast enucleation. Stem Cells Int 2011;2011:139851.
50. Ji P, Yeh V, Ramirez T et al. Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts. Haematologica 2010;95:2013-2021.
51. Li LB, Leung DY, Martin RJ et al. Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor beta in steroid-resistant asthma. Am J Respir Crit Care Med 2010;182:877-883.
52. Miharada K, Hiroyama T, Sudo K et al. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol 2006;24:1255-1256. (Pubitemid 44564771)
53. Keerthivasan G, Small S, Liu H et al. Vesicle trafficking plays a novel role in erythroblast enucleation. Blood 2010;116:3331-3340.
54. Chang AH, Stephan MT, Sadelain M. Stem cell-derived erythroid cells mediate long-term systemic protein delivery. Nat Biotechnol 2006;24:1017-1021. (Pubitemid 44215396)
55. Win N, New H, Lee E et al. Hyperhemolysis syndrome in sickle cell disease: Case report (recurrent episode) and literature review. Transfusion 2008;48:1231-1238. (Pubitemid 351793504)
56. Chasovskyi K, Fedevych O, Vorobiova G et al. Arterial switch operation in the first hours of life using autologous umbilical cord blood. Ann Thorac Surg 2012 [Epub ahead of print].
57. Papadopoulos KI, Low SS, Aw TC et al. Safety and feasibility of autologous umbilical cord blood transfusion in 2 toddlers with cerebral palsy and the role of low dose granulocyte-colony stimulating factor injections. Restor Neurol Neurosci 2011;29:17-22.